Elevated concentrations of cytokines were found in the plasma of patients acutely ill with Reye syndrome (RS) but not in control subjects or recovered RS patients. To determine whether this disorder involves a genetically determined abnormal response to cytokines, the effects of tumor necrosis factor (TNF) and IL-I on intracellular free Ca2" were compared in cultured skin fibroblasts from control subjects and patients with RS. IL-1 and TNF caused rapid, transient, and concentration-dependent increases in cytosolic free Ca2". The peak cytosolic free Ca2" was greater and occurred at higher concentrations of IL-1 and TNF in patient cells than in cells from age-matched controls. In control cells, the Ca2" transient diminished sharply with increasing amounts of IL-1 or TNF above the maximum stimulatory concentration. In contrast, in patient fibroblasts this bell-shaped curve of concentration dependency was much less apparent. Bradykinin-stimulated Ca2" transients were similar in the two groups and did not exhibit the bell-shaped concentration dependency. Thus, plasma cytokine levels are elevated in RS patients and the Ca2" response to cytokines is increased in cells derived from these patients. We propose that the increased response reflects a genetic defect in cytokine receptor-modulated signal transduction. (J. Clin. Invest. 1991. 
Introduction
For more than 25 years, researchers have been seeking the cause of Reye syndrome (RS),' an often fatal hepatic encephalopathy that strikes children treated with aspirin during a viral illness (1) (2) (3) (4) (5) . Our previous studies were focused on the liver (6) , where disturbances in lipid metabolism appeared to play a role in the pathology ofthe disease. Based on finding large amounts of hepatic acyl CoA metabolites of lipid oxidation known to inhibit many enzymes (6-13), we suggested that mitochondrial ,8-oxidation is blocked at multiple acyl CoA dehydrogenases.
Although these observations can explain the hyperammonemia, hypoglycemia, and hepatic pathology seen in RS, they do not identify the cause of the disorder.
A genetic defect, viral infection, salicylate toxicity, endotoxin, and these factors in combination have been put forth as possible causes of RS (2, 3, (14) (15) (16) (17) (18) (19) (20) . It has also been suggested that cytokines such as IL-I or tumor necrosis factor (TNF) may play a key role in the pathogenesis of this disease. TNF and IL-1 production follow viral infection or endotoxin stimulation (16, (19) (20) (21) (22) (23) (24) (25) . A more recently identified cytokine (26) , IL-6, produced by fibroblasts (27) and certain other cell types, shares many actions with TNF and IL-1 but with apparently greater hepatic specificity (26) . These cytokines are believed to be the endogenous mediators of the toxic effects of endotoxin in vivo (23) (24) (25) (26) (27) (28) (29) (30) (31) . Increased plasma levels of endotoxin have been found in RS (32) . Moreover, aspirin amplifies TNF production in vitro (16) and thus indirectly may stimulate IL-1 production (21). Larrick and Kunkel proposed that RS is caused by augmented production of TNF, which they showed was exacerbated by aspirin (16) . Kilpatrick et al. have extended this proposal and suggested that cytokines inhibit mitochondrial ,3-oxidation as part oftheir hepatic action (18) . In support of this concept we have demonstrated an accumulation of inhibitory acyl CoA esters in livers of rats treated with low doses ofendotoxin together with aspirin (18) , a pattern similar to that observed in patients with RS (6) .
IL-1 and TNF mediate pleiotropic pro-inflammatory effects on many cell types by an as yet unidentified signal transduction pathway (21, 22) . We have measured the cytokines IL-1, TNF, and IL-6 and found them greatly elevated during the acute phase of RS. The present study also compares the early actions and interactions of IL-1 and TNF with that of bradykinin (BK) in human fibroblasts. We examined fibroblasts because they were available from several patients who had had RS and they express many defects characteristic of Reye-like syndromes. We focused on cytosolic free Ca2" as a second messenger of stimulus-response coupling. Mitogenic stimulation by a variety of growth factors including BK transiently increases cytosolic free Ca2", independently of external Ca2" (33) , presumably by activation of phosphatidylinositol 4, 5 bisphosphate (PIP2)-specific phospholipase C (34 Table I . Control cells were from age-inatched subjects without known metabolic disease.
Cytokine assays. Plasma samples were obtained from eight healthy control subjects and eight children (7-15 yr) during their acute illness who had been diagnosed with RS between 1982 and 1989. Plasma was stored at -70°C before assay. Analyses were performned using IL-Id and TNF-a ELISA kits (Cistron Biotechnologies, Pine Brook, NJ). Before IL-1( and TNF-a measurements, plasma samples were extracted twice with two volumes of chloroform according to the method of Cannon et al. (35) . The IL-6 ELISA kit was obtained from Genzyme Corp. (Boston, MA). Duplicate determinations were done for each plasma sample. IL-I, TNF-a, and IL-6 were not detectable in any of the parallel control samples or recovered RS patients. The limits of detection were 20 pg/ml for TNF-a, 4 pg/ml for IL-I B, and 0.3 ng/ml for IL-6.
Fibroblast growth and preparation. Cells were grown in L-15 medium containing 5% Serumax (Sigma Chemical Co., St. Louis, MO). Cells were removed from culture flasks by incubating for 8-10 min in 0.02% EDTA in Dulbecco's PBS or for 2-5 min in 0.05% trypsin. The Ca2" responses of cells removed by either technique were similar, indicating that trypsin did not impair the cytokine receptor.
Ca2" measurement. Cytosolic free Ca2" was d.-termined from changes in the excitation signals of the fluorescent indicator fura 2 at 340 and 380 nm, measuring emission at 510 nm (36) , using a timesharing fluorometer built and designed by the Bio Instrumentation Group (University of Pennsylvania) (37) .
Cells were loaded with fura 2 using L-15 tissue cultuire medium with 15 mM Hepes, pH 7.4, containing 0.5% fatty acid frse, dialyzed BSA filtered through a 0.45-,um Millipore filter. Cells were suspended in modified Krebs-Hepes buffer containing 120 mM4 NaCl, 5 mM NaHCO3, 2 mM CaCI2, 1 mM MgCI2, 10 mM glucose, 10 mM Hepes, and 0.5% BSA, pH 7.4. The cytosolic free Ca2+ was calculated as described previously (36, (38) (39) (40) 17 kD, a specific activity of 108 U/mg, and is supplied at a concentration of 200 U/ml. TNF-a, the only purified natural form of this cytokine, has a molecular mass of 17 kD, contains 108 U/mg, and is supplied at a concentration of4,000 U/ml. Recombinant human IL-1(3 was from Cistron Biotechnologies, 500 U/ml and 106 U/mg, 95% pure with < 50 pg/Ag of endotoxin.
Results
The relevance of cytokine effects on signal transduction depends on elevations of these compounds in patients during the course of their illness. The plasma levels of cytokines in patients with RS are shown in Table II Cytokine levels were measured using ELISA kits. Plasma samples from eight control subjects and two patients after recovery were below the level of detection. Patient designations 1-5 are the same as in Table I . Plasma was not available from patient 2 during the illness. The staging of Reye syndrome was according to criteria set forth by the Communicable Disease Center (2). * Patient died.
$Serum sample.
days, it appears that rather dramatic changes in the three cytokines develop with time. Elevated TNF concentrations occurred in all of the patients tested. Cytokine levels were generally highest in the patients who died (indicated with an asterisk in Table II ). Patients 1 and 5, from whom blood samples were obtained on their last day of life, exhibited extremely high IL-6 concentrations at a time when TNF had diminished. To study IL-I and TNF effects on signal transduction in human tissue, fibroblasts from patients 1 to 5 and five age-matched control subjects were obtained and used for the subsequent studies. Plasma from patient 2 was not available during the acute illness but fibroblasts and plasma were obtained several months after recovery.
Fibroblasts exhibit increases in cytosolic free Ca2" in response to the peptide growth factor BK (33, 34, 42) . Fig. 1 analyses for patients. Asterisks indicate a value that differs significantly from the control value according to Student's t-test.
cytosolic free Ca2". Similar data were obtained in two additional cell lines (data not shown). 2 Basal cytosolic free Ca2+ levels obtained in patients and control cell lines did not differ significantly (83±9, n = 96, for controls and 78±7 nM, n = 80, for patients), nor did maximal peak responses to 1 ,M BK (888±192 nM, n = 19, for controls and 976±159 nM, n = 16, for patients). Increasing BK concentrations above the maximal level did not alter the observed Ca2" peak (data not shown). However, cells from patients with RS responded to IL-I and TNF with higher maximum Ca2" peaks and right-shifted concentration response curves compared with cells from control subjects. To characterize this difference detailed concentration dependencies were obtained.
The mean peak Ca2" transients at different concentrations of IL-I are shown in Fig. 2 . The concentration dependency curves below 300 mU/ml are similar for control and patient groups. However, higher peak increases were obtained in the patient group and hence both peak responses (240 nM Ca2" at 250 mU/ml IL-1 for control vs. 500 nM Ca2" at 400 mU/ml IL-I for patients) and the half-maximal IL-1 concentrations (170 mU/ml for control vs. 350 mU/ml for patients) were higher in patient than in control cells. In addition the declining portion of the bell-shaped curve or inhibitory phase of the response occurred at lower concentrations of IL-1 in the control group (half-maximal Ca2' response at 750 mU/ml) than in the patients (half-maximal at 2 U/ml). Although variations in the concentration dependency at high IL-1 levels were observed among patients, a decreased Ca2" transient was observed above 5 U/ml IL-I in cells from all patients.
The mean Ca2+ transients obtained from fibroblasts at different concentrations of TNF are shown in Fig. 3 . The maximal Ca2' peak in patient cells occurred at 8 U/ml TNF and in control cells at 4 U/ml TNF. In addition, the calculated TNF levels at which half-maximal inhibition of the Ca2+ peak oc-2. Attempts to block the response to IL-1 with specific antibodies to IL-I were unsuccessful since both immune and nonimmune sera induced Ca2" transients. . Fura 2-loaded human fibroblasts from five control subjects and four patients were incubated as described in Fig.  1 Figure 4 . IL-1-and TNF-induced Ca2" transients are dependent on intracellular Ca2" stores. Fura 2-loaded fibroblasts were incubated as described in Fig. 1 , except traces A and C contained no Ca2' and 100 ,uM EGTA. IL-I was added at 400 mU/ml, TNF at 2 U/ml, and ionomycin at 2 AM, as indicated. These traces illustrate experiments that were performed at least three times with control and patient cell lines. served with BK (data not shown), consistent with previous reports in the literature (33, 45) .
Because of the apparently similar mechanism of Ca2' rise induced by the three agonists tested, the interactions among them were investigated. Fig. 5 A shows that prior addition of a maximal stimulatory concentration of BK blunts the response to IL-1 (compare traces A and E). The ability ofTNF to diminish the response to IL-1 depended on the concentration ofTNF (Fig. 5, B and C) . Below the maximal concentration of TNF (Fig. 5 B) , a large IL-1 response followed the small TNF response, whereas at a near maximal concentration of TNF (Fig.  5 C) , the IL-1 response was largely inhibited. The ability of BK to increase Ca2+ was similarly influenced by prior addition of IL-I and TNF (TNF data not shown).
It was not clear from the previous data whether the first agonist impaired the response to the second agonist through a membrane receptor event, competition for the same Ca2+ pools or generation of a second messenger such as diacylglycerol. Increasing IL-1 concentrations elicited the type of bell-shaped curve (Fig. 5 , D-F) described in Fig. 2 . However, the ensuing BK response appeared to depend on the magnitude ofthe Ca2+ transient rather than on the concentration of IL-1. Thus the response to BK was greatly diminished after a maximal IL-1-induced Ca2+ transient (Fig. 5 E) , but increased after a higher but less effective dose of IL-1 (Fig. 5 F) . These data suggest that the interaction among agonists is distal to receptor binding. The different agonists may compete for the same internal stores or the first agonist may activate protein kinase C.
Short-term exposure of cells to the phorbol ester PMA activates protein kinase C, which in some cell types appears to feedback-inhibit Ca2+ responses (for review see references 46 and 47), probably by protein kinase C-mediated block of receptor-induced PIP2 breakdown (48) . Longer exposure to phorbol esters appears to deplete cellular protein kinase C content, preventing this feedback mechanism (47). The Ca2+ transients caused by IL-1 and TNF were diminished in fibroblasts from control subjects and patients by short ( Figure 6 . Effect of phorbol esters (PMA) on cytosolic free Ca2" in cultured human fibroblasts from control subjects (A-C) and patients with Reye syndrome (D-F). Fura 2-loaded human fibroblasts were incubated as described in Fig. 1 (Fig. 6 C) . The patient cells exhibited lower basal Ca2' and diminished response to TNF (Fig. 6 F) , although the significance of these findings is not understood. In addition, the inhibitions observed at high concentrations of IL-1 and TNF were retained in both patient (Fig. 7 ) and control (data not shown) cells after long-term exposure to phorbol esters, suggesting that the inhibitory phase of the concentration curve was not mediated by protein kinase C activation. Furthermore, the enhanced response to BK at higher, less effective, concentrations of IL-1 and TNF were also retained after long-term exposure to PMA (Fig. 7 , compare A-D with E-H), indicating that the agonists compete for the same internal stores. The recent demonstration that IL-I and TNF rapidly increase cAMP levels in thymocytes (49) and human fibroblasts (27) prompted evaluation of the role of cAMP in cytokine-mediated Ca2+ transients. We asked specifically whether exposure to forskolin, which activates adenylate cyclase and elevates cAMP, or the cAMP analogue, dibutyryl cAMP, modulated IL-1-and TNF-induced Ca2+ peaks. We found that both forskolin (data not shown) and dibutyryl cAMP (Fig. 8) increased cytosolic free Ca2 . In contrast to the response previously observed in cultured clonal f-cells (39) , the Ca2+ rise in the fibroblasts was independent of extracellular Ca2+ and was inhibited by 15 min pretreatment with PMA (data not shown). When IL-1 was added before dibutyryl cAMP, the response to dibutyryl cAMP was markedly diminished (Fig. 8 A) . However, dibutyryl cAMP added before IL-1 exerted little effect on the IL-1-induced Ca2+ transient (Fig. 8 B) , even at concentrations as high as 1 mM (Fig. 8 C) Figure 7 . Effect of phorbol esters (PMA) on interactions between cytokines and BK in cultured human fibroblasts from patients with Reye syndrome. Fura 2-loaded fibroblasts were incubated as described in Fig.  1 . TNF and IL-1, at concentrations indicated, and BK (1 ,uM) were added in the absence of added PMA (A-D) or in cells treated for 16 h (E-H) with 1 qM PMA. These traces illustrate experiments that were performed at least three times with control and patient cell lines. Figture 8. Illustration of the interaction between IL-I and dibutyryl cAMP (DBcAMP) in cultured human fibroblasts. Fura 2-loaded human fibroblasts were incubated as described in Fig. 1 Ca" responses, higher half-maximal cytokine concentrations for observed Ca>2 effects, and blunted inhibition of the Ca>2 response at high cytokine levels.3 This may be a genetic characteristic of patients with RS since it is retained through many passages in tissue culture and is observed in all five of the patients evaluated in this study, including one patient from whom fibroblasts were obtained several months after recovery. Additional proof of a genetic defect in cytokine signal transduction will require follow-up studies of surviving patients and their families. The physiological relevance of the observed effects of high and low cytokine levels must be related to the actual concentrations that prevail in vivo. Others have reported values for IL-1 3 . In preliminary studies, we also found that growth stimulation of fibroblasts by the cytokines was greater in patient cells at high cytokine concentrations.
(from < 20 mU/ml to 5 U/ml, which is equivalent to 0.2-50 pg/ml) and TNF (I0 pg/ml to 30 ng/ml, which is equivalent to 0. 1-300 U/ml) in patients with various diseases such as septic shock and hepatic failure (53) (54) (55) . The average values obtained from our patients (Table II) of -20 pg/ml (2 U/ml) for IL-I and 10 ng/ml (100 U/ml) for TNF are at the high end of this range. In addition, we found that TNF elevations preceded IL-I and IL-6 increases in three of four patients from whom multiple samples were obtained, consistent with the suggestion by Fong and Lowry (56) of a feedback loop in which TNF stimulates IL-I and IL-6 production and the latter cytokine in turn inhibits TNF production.
IL (58, 66, 67) .
The bell-shaped concentration curve suggests that IL-I and TNF may operate through two mutually incompatible signal transduction pathways: a Ca2+-mediated pathway at low cytokine concentrations; and a second, as yet undefined, pathway that prevents cytokine-induced Ca2+ transients. Bell-shaped curves are also observed for a number of other responses to IL-I and TNF (27, 57, 58, 68) . Although the significance and mechanism ofthis phenomenon is not known, several possible explanations may pertain. First, the bell-shaped response curve could represent two independent actions of the cytokines mediated through two receptor subtypes each linked with a different effector system. Several groups have reported two classes of binding sites, although no correlation between binding and action has been demonstrated (22, 69, 70) . A second possibility is that receptor-ligand internalization (69, 71) is an essential step in cytokine-mediated Ca2" transients and is inhibited at high receptor occupancy. Third, the cytokines could interact with two different effector systems through the same receptor depending on ligand-receptor occupancy. Thus, a low level cytokine-receptor interaction could involve G-protein stimulation of a PIP2-specific phospholipase C, whereas multiple cytokinereceptor units, which might exhibit a structurally altered complex, could promote interaction with different G-proteins and thus other effectors.
The relationship between Ca2' hyperresponsiveness to high concentrations of IL- 1 A hypothetical working model of the pathophysiology of RS involves the inability to turn off the Ca2" signal at high cytokine concentrations. It is suggested that this defect leads to cell damage either directly, by blocking responses to other agonists, or indirectly, through production of IL-6. We propose that this destructive process involves inhibition of fatty acid oxidation. Stimulation of fatty acid synthesis, which has been noted to accompany cytokine elevation (28) (29) (30) , presumably results from malonyl CoA-mediated inhibition of fatty acid oxidation (75) (76) (77) with resulting increases in cytosolic long chain acyl CoA levels (77) . Because of the specific pattern of metabolic accumulation (6) it may be postulated that diminished energy production follows specific inhibition of amino and fatty acid oxidation at flavin-linked enzymes, resulting in accumulation of acyl CoA substrates for these enzymes. If the model is correct, inhibition of the Ca2+ transient, together with provision of substrate not requiring flavin-linked enzymes, such as glucose, might protect patients during the acute phase of the illness. The pathological consequences of alteration of the bell-shaped response curve would only appear, as in patients who develop RS, when three conditions co-exist: (a) A viral illness that stimulates local cytokine production by circulating monocytes or tissue-fixed macrophages; (b) the addition of aspirin to amplify cytokine production; and (c) a genetic or acquired loss of the protective inhibitory component of the response to high cytokine levels.
